ES461020A1 - Procedimiento para la preparacion de composiciones para la liberacion controlada de agentes cardiacos y circulatorios. - Google Patents

Procedimiento para la preparacion de composiciones para la liberacion controlada de agentes cardiacos y circulatorios.

Info

Publication number
ES461020A1
ES461020A1 ES461020A ES461020A ES461020A1 ES 461020 A1 ES461020 A1 ES 461020A1 ES 461020 A ES461020 A ES 461020A ES 461020 A ES461020 A ES 461020A ES 461020 A1 ES461020 A1 ES 461020A1
Authority
ES
Spain
Prior art keywords
drug core
group
coated
drug
gastric juices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461020A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES461020A1 publication Critical patent/ES461020A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES461020A 1976-07-27 1977-07-26 Procedimiento para la preparacion de composiciones para la liberacion controlada de agentes cardiacos y circulatorios. Expired ES461020A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (1)

Publication Number Publication Date
ES461020A1 true ES461020A1 (es) 1979-05-01

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
ES461020A Expired ES461020A1 (es) 1976-07-27 1977-07-26 Procedimiento para la preparacion de composiciones para la liberacion controlada de agentes cardiacos y circulatorios.

Country Status (27)

Country Link
JP (1) JPS5315411A (enrdf_load_html_response)
AR (1) AR216479A1 (enrdf_load_html_response)
AT (1) AT369987B (enrdf_load_html_response)
AU (1) AU515738B2 (enrdf_load_html_response)
BE (1) BE857122A (enrdf_load_html_response)
CA (1) CA1095833A (enrdf_load_html_response)
CY (1) CY1261A (enrdf_load_html_response)
DE (1) DE2732335C2 (enrdf_load_html_response)
DK (1) DK325677A (enrdf_load_html_response)
ES (1) ES461020A1 (enrdf_load_html_response)
FI (1) FI772217A7 (enrdf_load_html_response)
FR (1) FR2359607A1 (enrdf_load_html_response)
GB (1) GB1589982A (enrdf_load_html_response)
GR (1) GR65014B (enrdf_load_html_response)
HK (1) HK81884A (enrdf_load_html_response)
HU (1) HU178340B (enrdf_load_html_response)
IE (1) IE45534B1 (enrdf_load_html_response)
IL (1) IL52587A (enrdf_load_html_response)
KE (1) KE3441A (enrdf_load_html_response)
MY (1) MY8400057A (enrdf_load_html_response)
NL (1) NL176227C (enrdf_load_html_response)
NO (1) NO149874C (enrdf_load_html_response)
NZ (1) NZ184722A (enrdf_load_html_response)
PT (1) PT66850B (enrdf_load_html_response)
SE (1) SE437469B (enrdf_load_html_response)
SG (1) SG53884G (enrdf_load_html_response)
ZA (1) ZA774536B (enrdf_load_html_response)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (enrdf_load_html_response) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
CA1095833A (en) 1981-02-17
NZ184722A (en) 1980-10-24
SE7708265L (sv) 1978-01-28
AU2730177A (en) 1979-02-01
NL7708162A (nl) 1978-01-31
IE45534B1 (en) 1982-09-22
NO772575L (no) 1978-01-30
JPS5726650B2 (enrdf_load_html_response) 1982-06-05
GB1589982A (en) 1981-05-20
AU515738B2 (en) 1981-04-30
DK325677A (da) 1978-01-28
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
HK81884A (en) 1984-11-25
BE857122A (fr) 1978-01-25
DE2732335C2 (de) 1983-01-20
DE2732335A1 (de) 1978-02-02
FR2359607A1 (fr) 1978-02-24
AT369987B (de) 1983-02-25
IL52587A (en) 1980-09-16
NL176227B (nl) 1984-10-16
PT66850B (fr) 1979-03-13
NO149874C (no) 1984-07-11
ZA774536B (en) 1979-02-28
KE3441A (en) 1984-09-14
AR216479A1 (es) 1979-12-28
NO149874B (no) 1984-04-02
NL176227C (nl) 1985-03-18
IL52587A0 (en) 1977-10-31
ATA541377A (de) 1982-07-15
JPS5315411A (en) 1978-02-13
MY8400057A (en) 1984-12-31
SE437469B (sv) 1985-03-04
SG53884G (en) 1985-03-08
FI772217A7 (enrdf_load_html_response) 1978-01-28
CY1261A (en) 1984-11-23
FR2359607B1 (enrdf_load_html_response) 1980-02-22
GR65014B (en) 1980-06-13
PT66850A (fr) 1977-08-01
DK325877A (da) 1978-01-20

Similar Documents

Publication Publication Date Title
US4410545A (en) Carbonate diester solutions of PGE-type compounds
US4328245A (en) Carbonate diester solutions of PGE-type compounds
ES461020A1 (es) Procedimiento para la preparacion de composiciones para la liberacion controlada de agentes cardiacos y circulatorios.
ES8502333A1 (es) Un procedimiento para la preparacion de una tableta farmaceutica
ES2071976T3 (es) Metodo de tratamiento de tumores solidos y composicion.
KR880001288A (ko) 경구투여 형태의 서방성 약제학적 조성물
DK0825858T3 (da) Flerumættede omega-3-fedtsyrer til behandling af inflammatorisk tarmsygdom i kapsler med tidsafhængig frigivelse
ES8101887A1 (es) Procedimiento para obtener una preparacion farmaceutica que comprende un glicorido cardiaco con un revertimiento de po- limero
ES8101894A1 (es) Procedimiento de obtencion de una matriz polimerica de difu-sion
ES2136618T3 (es) Cicatrizacion de heridas.
JPS5579323A (en) Base
KR870009717A (ko) 신규 경구용 약제
ES403435A1 (es) Metodo para la preparacion de una composicion farmaceutica de liberacion lenta.
JPS53107408A (en) Micellar preparation for rectal infusion
GB1510999A (en) Pharmaceutical preparation in the form of a foil having an active substance incorporated therein
AR017801A1 (es) Una composicion de preconcentrado en microemulsion que contiene ciclosporina, y una formulacion farmaceutica que la comprende
ES460669A1 (es) Procedimiento para la fabricacion de una tableta de limpiezaespontanea de protesis dentales en solucion acuosa.
ES2076412T3 (es) Proceso para la fabricacion de microesferas.
CO5380014A1 (es) Formulacion farmaceuticas para la administracion oral o topica de compuestos hidrofobicos que no frma emulsion
ES395533A1 (es) Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico.
AR016629A1 (es) Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica.
AR036797A1 (es) Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
CN104276962A (zh) 一种阿司匹林衍生物及其组合物与应用
JPS5350316A (en) Drug composition for oral administration
Arakawa et al. Gastric cytoprotection by tetraprenylacetone in human subjects

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990601